🔗 Share this article

While the United States proceeds with unprecedented revisions to its vaccination schedules, an unexpected name has emerged in a surprising turn: Dr. Tracy Beth Høeg, an American of Danish descent sports medicine doctor and epidemiologist who initially gained attention by expressing skepticism about Covid vaccinations during the global health crisis and has concentrated on alleged fatalities after COVID-19 immunization in her recent time at the Food and Drug Administration.

Planned Changes to Pediatric Vaccine Schedule

Health officials had intended to announce major changes to the childhood vaccine schedule recently, bringing the US with the Danish vaccine program, sources say – a substantial departure that would place the US out of alignment with much of the international standard with insufficient data for benefit. This reveal has been pushed back until the next year.

Rather than the top vaccines chief, Tracy Beth Høeg is listed to present at the event. She was recently named temporary leader of the FDA’s drug evaluation center, the fifth individual to lead the office this year.

A New Direction at the Agency

The acting appointment might represent a closer partnership between the drug and biologics centers as Dr. Høeg and Dr. Prasad strengthen their influence at the agency – and it signals a renewed priority upon dismantling previously authorized vaccines at the FDA.

Høeg has frequently advocated for discontinuing certain pediatric immunization guidelines in the US so as to align more similar to the Danish model, a nation with universal health coverage and a citizenry roughly the population of Wisconsin’s.

In her initial public appearances, she has kept her attention on vaccines – usually the purview of Dr. Prasad, chief of the FDA’s CBER – rather than drug regulation.

Doubts Over Qualifications

Høeg has little discernible experience in drug development, oversight or administrative roles, which has been standard for past leaders of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a key advisor to the commissioner and the vaccine center since earlier this year.

“It seems she lacks to have any of the qualifications” for running the drug-regulation department, remarked Dr. Jonathan Howard. “She’s never run a clinical trial. She has no expertise in leading a large organization. She has no expertise in drug approvals.”

Past commissioners of the center would “grasp regulatory frameworks and the research of drug development”, said Dr. Janet Woodcock. “Objectively, she has not acquired the kind of background that former directors who headed the center have had.”

CDER has an immense workload at the FDA, she emphasized.

“The public just focuses on the novel medication approvals, but the generic program approves a multitude of generic medications. There is also a biosimilars division, non-prescription drug unit and more, and all of those need to be looked after,” Dr. Woodcock said. “The responsibility you don’t keep your eye on, that is the part that I always told people is going to come back to haunt you.”

Furthermore, a major leadership aspect to the position, which manages over 5,000 personnel. “It’s a enormous management job, if you perform it correctly,” Woodcock added.

Response and Controversial Programs

Regarding questions about Høeg’s credentials and whether this selection indicates increased cooperation among agency officials on immunizations, a press secretary said that the “questions are based on incorrect premises”.

“Her experience aligns with the duties of her position,” the spokesperson stated, pointing to the period Høeg spent advising the agency head on “pharmaceutical safety and approval science, including computerized risk analysis and vaccine surveillance”.

As acting director, Høeg takes over the commissioner’s new fast-track approval initiative, a contentious expedited drug-approval program that allegedly worried her predecessors. “By what process are these medications being picked for this expedited pathway? Who is making the decisions?” Howard asked. “There’s a lot of confidentiality occurring at the regulatory body right now.”

Broadly speaking, he stated, “the agency appears to be shifting towards laxer oversight of most medications, aside from immunizations.”

Established Past Work on Vaccines

With immunizations, Dr. Høeg has a more documented, if troubling, past, Howard observe. She authored a research paper using unconfirmed crowd-sourced reports to assess the incidence of myocarditis following Covid immunization. She consulted for the Florida surgeon general Joseph Ladapo, who reportedly have modified findings to imply Covid vaccinations are pose a greater threat than they are.

Among her “wish list” for the new government featured revising rules for novel immunizations and ending “optional” immunizations, she stated post-election on a podcast. At the agency, Høeg has according to sources proposed excluding young men from receiving Covid vaccinations.

“She’s an complete dogmatist who starts off with her preconceived notions and works backwards to fit the data in a extremely misleading, fraudulent way,” Howard argued.

Consolidating Power and a “Campaign of Retribution”

Høeg became part of other skeptics, {like|